Delivery Order SPE2DB25D3202-SPE2DB25FSZDA

Award Date 12/18/24
Potential Completion Date 12/19/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB25D3202
    Indefinite Delivery Contract
  • SPE2DB25D3202-SPE2DB25FSZDA
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,554.95 Firm Fixed Price delivery order is for the supply of 4,566,760,843 units of Ondansetron ODT 8 mg tablets, a medication commonly used to treat nausea and vomiting.

The contract has an ultimate completion date of December 19, 2024 and was awarded on December 18, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued against that larger IDC contract.

Generated 3/23/25, 1:04 AM